Guidance for industry : collection of race and ethnicity data in clinical trials.
| Corporate Authors: | Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), Center for Devices and Radiological Health (U.S.), United States. Food and Drug Administration. Office of the Commissioner |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
Rockville, MD :
U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research : Center for Devices and Radiological Health : Office of the Commissioner,
[2005]
|
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/LPS114927 |
Similar Items
Guidance for industry : E 10 choice of control group and related issues in clinical trials.
Published: (2001)
Published: (2001)
Guidance for industry : information program on clinical trials for serious or life-threatening diseases and conditions.
Published: (2002)
Published: (2002)
Guidance for industry : acceptance of foreign clinical studies.
Published: (2001)
Published: (2001)
Guidance for industry : E9 statistical principles for clinical trials.
Published: (1998)
Published: (1998)
Guidance for clinical trial sponsors : establishment and operation of clinical trial data monitoring committees.
Published: (2006)
Published: (2006)
Guidance for industry : computerized systems used in clinical trials.
Published: (1999)
Published: (1999)
Guidance for industry : gene therapy clinical trials, observing subjects for delayed adverse events.
Published: (2006)
Published: (2006)
Guidance for industry : independent consultants for biotechnology clinical trial protocols.
Published: (2004)
Published: (2004)
Guidance for industry : submitting and reviewing complete responses to clinical holds.
Published: (2000)
Published: (2000)
Guidance for industry : M4S, the CTD, safety.
Published: (2001)
Published: (2001)
Guidance for industry : M4S, the CTD, safety appendices.
Published: (2001)
Published: (2001)
Guidance for industry : postmarketing studies and clinical trials, implementation of section 505(o) of the Federal Food, Drug, and Cosmetic Act.
Published: (2009)
Published: (2009)
Guidance for industry : E 10 choice of control group and related issues in clinical trials.
Published: (2001)
Published: (2001)
Guidance for industry : IND exemptions for studies of lawfully marketed drug or biological products for the treatment of cancer.
Published: (2004)
Published: (2004)
Guidance for industry : M4Q, the CTD, quality.
Published: (2001)
Published: (2001)
Guidance for industry : E6 good clinical practice, consolidated guidance.
Published: (1996)
Published: (1996)
Guidance for industry : toxicity grading schedule for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials.
Published: (2007)
Published: (2007)
Reviewer guidance : conducting a clinical safety review of a new product application and preparing a report on the review.
Published: (2005)
Published: (2005)
Guidance for industry : M4E, the CTD, efficacy.
Published: (2001)
Published: (2001)
Guidance for industry : computerized systems used in clinical investigations.
Published: (2007)
Published: (2007)
Clinical trials roadmap for physician practices /
by: Morgan, Christie L.
Published: (2004)
by: Morgan, Christie L.
Published: (2004)
Guideline for the monitoring of clinical investigations.
Published: (1988)
Published: (1988)
Guidance for industry : E2BM data elements for transmission of individual case safety reports.
Published: (2002)
Published: (2002)
Guidance for industry : supplemental guidance on testing for replication competent retrovirus in reroviral vector based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors.
Published: (2006)
Published: (2006)
Guidance for clinical investigators, institutional review boards, and sponsors : process for handling referrals to FDA under 21 CFR 50.54 : additional safeguards for children in clinical investigations.
Published: (2006)
Published: (2006)
Guidance for industry : E2B(M), data elements for transmission of individual case study reports, questions and answers.
Published: (2005)
Published: (2005)
Implementing a national cancer clinical trials system for the 21st century : workshop summary /
Published: (2011)
Published: (2011)
A first-order characterization of clinical trials /
by: Hopwood, Marsha
Published: (1980)
by: Hopwood, Marsha
Published: (1980)
Structure and content of clinical study reports.
Published: (1996)
Published: (1996)
Guidance for clinical investigators, sponsors, and IRBs : adverse event reporting to IRBs : improving human subject protection.
Published: (2009)
Published: (2009)
Guidance for industry : M4, the CTD, general questions and answers.
Published: (2004)
Published: (2004)
Guidance for industry : M4, the CTD, efficacy questions and answers.
Published: (2004)
Published: (2004)
21st Century Cures : Modernizing Clinical Trials.
Published: (2014)
Published: (2014)
The relevance of ethnic factors in the clinical evaluation of medicines /
Published: (1994)
Published: (1994)
Developing a national registry of pharmacologic and biologic clinical trials : workshop report /
Published: (2006)
Published: (2006)
Small clinical trials : issues and challenges /
Published: (2001)
Published: (2001)
PLoS clinical trials.
Published: (2006)
Published: (2006)
Guidance for industry : Prescription Drug Marketing Act, donation of prescription drug samples to free clinics.
Published: (2006)
Published: (2006)
An insider's guide to clinical trials /
by: Meinert, Curtis L.
Published: (2011)
by: Meinert, Curtis L.
Published: (2011)
Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals.
Published: (2008)
Published: (2008)